July 28, 2022 Comments Off on New patent expiration for Otsuka drug ABILIFY Posted in: Uncategorized
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPaten…
July 28, 2022 Comments Off on New patent for NOVO drug RYBELSUS Posted in: Patent Added Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWa…
